• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Grauch Edward Rowland was granted 6,109 shares, increasing direct ownership by 0.53% to 1,155,534 units

    12/19/22 4:21:41 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Get the next $BDR alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Grauch Edward Rowland

    (Last) (First) (Middle)
    C/O BLONDER TONGUE LABORATORIES, INC.
    ONE JAKE BROWN ROAD

    (Street)
    OLD BRIDGE NJ 08857

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    BLONDER TONGUE LABORATORIES INC [ BDRL ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    CEO & President
    3. Date of Earliest Transaction (Month/Day/Year)
    12/16/2022
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock, par value $0.001 12/16/2022 A(1) 6,109 A $0.17 1,155,534 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Pursuant to a Deferred Compensation Agreement between the reporting person and the issuer, on the date on which a portion of the reporting person's compensation has been deferred, the issuer accrued the number of shares indicated. The number of shares of common stock accrued represents the quotient of (i) the portion of compensation deferred divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the OTCQB on such date). These shares will be delivered to the reporting person during the first quarter of 2024.
    /s/ Edward R. Grauch by Eric Skolnik Under Power of Attorney 12/19/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BDR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BDR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BDR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blonder Tongue Laboratories Releases Clearview HEVC Video Transcoder

    Offering Broadcasters, Satellite and Cable Operators a Migration Path to Ultra Low Bandwidth Video DeliveryOLD BRIDGE, NJ / ACCESSWIRE / June 8, 2022 / Blonder Tongue Laboratories, Inc. (NYSE:BDR), a leading US-based designer and manufacturer of video and data transmission technologies, announced the release of their new ClearviewTM HEVC advanced IP video transcoder for use by broadcasters, satellite and cable television service providers currently in the process or planning a transition to the latest MPEG HEVC/H.265 international standard for video compression. The Clearview HEVC allows those broadcasters and service providers a cost-effective path to support all end customers requiring dig

    6/8/22 7:30:00 AM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Blonder Tongue Laboratories Announces Advanced Rack Mount Broadband Distribution Amplifier

    New RMDA 1000 offers expanded Bandwidth and FlexibilityOLD BRIDGE, NJ / ACCESSWIRE / May 23, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) today announced the release of its newest Rack-Mount Distribution Amplifier (RMDA), the RMDA 1000-42P, expanding on its best-selling broadband amplifier series. The RMDA 1000 is a completely self-contained high gain, 1 Gigahertz amplifier designed specifically for HFC signal distribution systems requiring low distortion characteristics.The RMDA 1000-42P has expanded bandwidth supporting up to 1002 MHz, with a 42dB high-gain design, making it useful in systems which use direct cable-drops as a signal source, or as the launch amplifier in a h

    5/23/22 8:00:00 AM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Blonder Tongue Reports First Quarter 2022 Results

    OLD BRIDGE, NJ / ACCESSWIRE / May 6, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced its sales and results for the first quarter ended March 31, 2022.Blonder Tongue Laboratories, Inc. net sales increased $90,000 or 2.8% to $3,341,000 for the first quarter of 2022 from $3,251,000 for the comparable period in 2021. Net loss for the three months ended March 31, 2022 was $(1,154,000) or $(0.09) per share, compared to $(414,000) or $(0.04) per share for the comparable period in 2021.Commenting on the Company's first quarter results, Chief Executive Officer Ted Grauch noted, "Despite continued strong demand for Blonder Tongue Laboratories' Clearview and Drake video encoding

    5/6/22 8:00:00 AM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $BDR
    SEC Filings

    View All

    Blonder Tongue Laboratories Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - BLONDER TONGUE LABORATORIES INC (0001000683) (Filer)

    1/23/23 5:10:39 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Blonder Tongue Laboratories Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - BLONDER TONGUE LABORATORIES INC (0001000683) (Filer)

    1/6/23 4:25:17 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form 10-Q filed by Blonder Tongue Laboratories Inc.

    10-Q - BLONDER TONGUE LABORATORIES INC (0001000683) (Filer)

    11/4/22 4:15:58 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $BDR
    Financials

    Live finance-specific insights

    View All

    Blonder Tongue Reports First Quarter 2022 Results

    OLD BRIDGE, NJ / ACCESSWIRE / May 6, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced its sales and results for the first quarter ended March 31, 2022.Blonder Tongue Laboratories, Inc. net sales increased $90,000 or 2.8% to $3,341,000 for the first quarter of 2022 from $3,251,000 for the comparable period in 2021. Net loss for the three months ended March 31, 2022 was $(1,154,000) or $(0.09) per share, compared to $(414,000) or $(0.04) per share for the comparable period in 2021.Commenting on the Company's first quarter results, Chief Executive Officer Ted Grauch noted, "Despite continued strong demand for Blonder Tongue Laboratories' Clearview and Drake video encoding

    5/6/22 8:00:00 AM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Blonder Tongue Schedules Conference Call to Discuss First Quarter 2022 Earnings Results

    OLD BRIDGE, NJ / ACCESSWIRE / April 28, 2022 / Blonder Tongue Laboratories, Inc. (NYSE:BDR) announced today it will report its First Quarter 2022 Earnings Results on Friday, May 6, 2022 prior to market opening. Management will then host a teleconference to discuss the results with the investment community.Details of the live teleconference:Date: Friday, May 6, 2022Time: 11:00 a.m. Eastern Time (10:00 a.m. CT, 8:00 a.m. PT)Toll Free: 888-506-0062International: 973-528-0011 Participant Access Code: 329982The audio replay will be available under Investor Related Information on the Blonder Tongue Investor Relations webpage.About Blonder Tongue LabsBlonder Tongue Laboratories, Inc. is the oldest

    4/28/22 4:05:00 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Blonder Tongue Reports Year End and Fourth Quarter 2021 Results

    OLD BRIDGE, NJ / ACCESSWIRE / March 31, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced its sales and results for the fourth quarter and year ended December 31, 2021.Commenting on the Company's year end and fourth quarter results, Chief Executive Officer Ted Grauch noted, "Although the Company was able to realize positive net earnings for the full year of 2021, the global semiconductor supply chain bottlenecks and supply uncertainties had a significant negative impact on our fourth quarter financial performance, and a number of those supply chain issues have continued into this year. We have been managing through this challenging environment with a combination of produ

    3/31/22 8:15:00 AM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $BDR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Blonder Tongue Laboratories, Inc. (Amendment)

    SC 13G/A - BLONDER TONGUE LABORATORIES INC (0001000683) (Subject)

    10/13/21 7:30:11 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form SC 13G/A filed

    SC 13G/A - BLONDER TONGUE LABORATORIES INC (0001000683) (Subject)

    2/10/21 3:17:50 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $BDR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Skolnik Eric S was granted 2,783 shares, increasing direct ownership by 3% to 99,012 units

    4 - BLONDER TONGUE LABORATORIES INC (0001000683) (Issuer)

    1/3/23 4:28:01 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form 4: Horvath Allen was granted 2,024 shares, increasing direct ownership by 1% to 165,906 units

    4 - BLONDER TONGUE LABORATORIES INC (0001000683) (Issuer)

    1/3/23 4:27:15 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form 4: Grauch Edward Rowland was granted 5,466 shares, increasing direct ownership by 0.47% to 1,161,000 units

    4 - BLONDER TONGUE LABORATORIES INC (0001000683) (Issuer)

    1/3/23 4:26:03 PM ET
    $BDR
    Radio And Television Broadcasting And Communications Equipment
    Technology